SVNS — Solvonis Therapeutics Share News
0.000.00%
Last trade - 00:00- £21.29m
- £20.53m
REG - Solvonis Therapeutic - SVN-SDN-14 PTSD - Positive pre-clinical results
AnnouncementREG - Solvonis Therapeutic - Total Voting Rights
AnnouncementREG - Solvonis Therapeutic - Translational Bridging Studies
AnnouncementREG - Solvonis Therapeutic - Exercise of warrants
AnnouncementRCS - Solvonis Therapeutic - Solvonis Chair to speak at Lucid Capital Markets
AnnouncementREG - Solvonis Therapeutic - £1m subscription to accelerate AI drug discovery
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - AGM Statement
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementRCS - Solvonis Therapeutic - Initiation of Research Coverage
AnnouncementREG - Solvonis Therapeutic - Allowance of U.S. patent covering AI-supported CNS
AnnouncementREG - Solvonis Therapeutic - Initiation of AI supported CNS drug discovery
AnnouncementREG - Solvonis Therapeutic - Synthesis of development candidate for SVN-SDN-014
AnnouncementREG - Solvonis Therapeutic - Notice of Annual General Meeting
AnnouncementREG - Solvonis Therapeutic - Appointment of Prof. David Nutt as CSO
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Total Voting Rights
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
AnnouncementREG - Solvonis Therapeutic - Holding(s) in Company
Announcement